CClinicalTrials.gg
CompletedNCT01784497Updated Oct 15, 2014

Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation

An observational study in Health Related Quality of Life, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2014-10-15.

Sponsored by Ain Shams University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
35
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation

Read the detailed description

This Study Aims to Evaluate:-

  1. Quality of life after LDLT In Egyptian patients using short form 36 (SF - 36) score.
  2. Impact of post transplant medical and psychiatric complications on quality of life
02

Conditions studied

  • Health Related Quality of Life

Keywords

  • Health Related Quality of Life (HRQL)
  • Living Donor Liver Transplantation(LDLT)
03

In context

Lead sponsor

Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients who will undergo LDLT In Ain Shams Center For Organ Transplantation (ASCOT) in the next 6 months.

Inclusion criteria

  • Adult Egyptian patients
  • 18-60 years old
  • Patients transplanted for HCV related disease and /or HCC
  • Informed consent

Exclusion criteria

Exclusion Criteria:

  • Other etiologies for end stage liver disease (such as HBV and cholestatic liver disease and autoimmune hepatitis).
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
35 participants (actual)
Patient registry
No

Groups and cohorts

  • Recipients of Living Donor Liver Transplantation

    Patients who will undergo Living Donor Liver Transplantation (LDLT) In Ain Shams Center For Organ Transplantation (ASCOT) .

06

What researchers measure

Primary outcomes

  1. Quality of life after LDLT In Egyptian patients using short form 36 (SF - 36) score.

    Time frame: 6 months

Secondary outcomes

  1. Impact of post transplant medical and psychiatric complications on quality of life

    Time frame: 6 months

07

Study locations

1 site
  • Ain Shams Center For Organ Transplantation (ASCOT),Ain Shams university
    Cairo, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 15, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01784497
Lead sponsor
Ain Shams University
Responsible party
Iman Fawzy Montasser (Lecturer of tropical medicine , Ain Shams university, Ain Shams University) — Principal investigator
First posted
Feb 6, 2013
Start date
Jan 2013
Primary completion
Oct 2014
Completion
Oct 2014
Last update
Oct 15, 2014

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion